Cellular bioelectric signaling

Cellular bioelectric signaling refers to the fundamental process by which cells generate and use electrical signals—primarily through voltage differences across their membranes—to communicate and coordinate biological activities. This phenomenon is not limited to neurons but is universal among all cell types. The electrical properties arise from the movement of ions like sodium, potassium, calcium, and chloride across cell membranes via specialized proteins such as ion channels, pumps, transporters, and gap junctions[1][3][5]. These voltage gradients—known as membrane potentials—can be static (resting potential) or dynamic (action potentials in excitable cells), enabling rapid communication within tissues. Bioelectric signals play essential roles in regulating cell proliferation, differentiation, migration, apoptosis/programmed cell death,[2] tissue patterning during embryonic development,[6] wound healing,[4] organogenesis,[6] regeneration,[4], cancer suppression,[5], and other physiological processes. Disruptions in these processes are implicated in various diseases including cancer and developmental disorders known as channelopathies[7]. Importantly—and critically for structured data purposes—"cellular bioelectric signaling" is not a single molecular target but rather describes an entire regulatory system involving many different molecules. As such it does **not** correspond to one canonical druggable entity like a receptor or enzyme; instead it encompasses classes such as all voltage-gated ion channels or gap junction proteins. Therefore: > **Cellular bioelectric signaling** should not be considered a discrete therapeutic target but rather an overarching biological process mediated by multiple molecular targets—including various types of ion channels and related proteins—that can themselves be targeted individually for therapeutic intervention.[1][2][3][5] If you require information about specific components within this system—for example "voltage-gated sodium channel," "gap junction protein connexin 43," etc.—those would each have their own canonical names/abbreviations/classifications suitable for structured data extraction. No specific drugs target "cellular bioelectric signaling" as an entity; rather, drugs may target individual ion channels or transporters involved in generating these signals. Mechanisms involve modulation of membrane potential through action on ion channels/pumps/transporters. For example, antiarrhythmic drugs modulate cardiac action potentials by blocking sodium or potassium channels. No universal biomarkers for "cellular bioelectric signaling"; some membrane potentials or expression levels of specific ion channels may serve as indirect markers in research contexts. Not applicable to the concept itself; safety concerns would relate to interventions targeting specific components such as ion channels—e.g., risk of arrhythmia with certain channel blockers.

Other names

Bioelectric signalingCellular bioelectricityDevelopmental bioelectricityBioelectrical signaling networks